Allscripts (MDRX) Announces New Share Buyback up to $300M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Boeing nears approval of 737 MAX anti-ice fix, paving way for deliveries
Allscripts Announces New Share Repurchase Program
November 18, 2020 8:01 AM ESTCHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions (NASDAQ MDRX) announced today that its Board of Directors has approved a new share repurchase program under which Allscripts may purchase up to $300 million of its common stock through December 31, 2021.
The new share repurchase program replaces the previously existing share repurchase program, which authorized Allscripts to repurchase $250 million of its common share through December 31, 2020. Allscripts has repurchased the entire amount available under the prior program.
"Extending and expanding Allscripts share repurchase program represents an attractive component of our capital deployment strategy," said Rick Poulton, Allscripts President and Chief Financial... More
